$4.48 Billion is the total value of Artal Group S.A.'s 77 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LXRX | LEXICON PHARMACEUTICALS INC | $617,743,000 | +33.4% | 57,517,978 | 0.0% | 13.80% | -30.7% | |
WW | WEIGHT WATCHERS INTL INC NEW | $187,848,000 | +31.5% | 29,443,300 | 0.0% | 4.20% | -31.7% | |
WMT | WAL-MART STORES INCcall | $107,959,000 | -8.6% | 1,665,000 | 0.0% | 2.41% | -52.5% | |
GE | GENERAL ELECTRIC COcall | $50,440,000 | -5.1% | 2,000,000 | 0.0% | 1.13% | -50.7% | |
AXP | AMERICAN EXPRESS COcall | $33,359,000 | -4.6% | 450,000 | 0.0% | 0.74% | -50.5% | |
GM | GENERAL MTRS COcall | $30,020,000 | -9.9% | 1,000,000 | 0.0% | 0.67% | -53.2% | |
QCOM | QUALCOMM INCcall | $26,865,000 | -14.2% | 500,000 | 0.0% | 0.60% | -55.5% | |
TEVA | TEVA PHARMACEUTICAL INDS LTDcall | $25,407,000 | -4.5% | 450,000 | 0.0% | 0.57% | -50.4% | |
MRK | MERCK & CO INC NEWcall | $24,695,000 | -13.2% | 500,000 | 0.0% | 0.55% | -54.9% | |
MCD | MCDONALDS CORPcall | $19,706,000 | +3.6% | 200,000 | 0.0% | 0.44% | -46.2% | |
ARRY | ARRAY BIOPHARMA INC | $16,918,000 | -36.8% | 3,710,000 | 0.0% | 0.38% | -67.2% | |
ISIS | ISIS PHARMACEUTICALS INC | $16,168,000 | -29.8% | 400,000 | 0.0% | 0.36% | -63.6% | |
CCI | CROWN CASTLE INTL CORP NEWcall | $15,774,000 | -1.8% | 200,000 | 0.0% | 0.35% | -49.1% | |
BAC | BANK AMER CORP | $15,580,000 | -8.5% | 1,000,000 | 0.0% | 0.35% | -52.5% | |
MU | MICRON TECHNOLOGY INCcall | $14,980,000 | -20.5% | 1,000,000 | 0.0% | 0.34% | -58.7% | |
GM | GENERAL MTRS CO | $13,509,000 | -9.9% | 450,000 | 0.0% | 0.30% | -53.3% | |
CCXI | CHEMOCENTRYX INC | $5,445,000 | -26.5% | 900,000 | 0.0% | 0.12% | -61.8% | |
JMEI | JUMEI INTL HLDG LTDsponsored adr | $4,935,000 | -56.8% | 500,000 | 0.0% | 0.11% | -77.6% | |
BTX | BIOTIME INC | $3,846,000 | -17.4% | 1,282,050 | 0.0% | 0.09% | -57.0% | |
CLLS | CELLECTIS S Asponsored ads | $3,295,000 | -26.9% | 125,000 | 0.0% | 0.07% | -61.9% | |
IRWD | IRONWOOD PHARMACEUTICALS INC | $2,260,000 | -13.6% | 216,879 | 0.0% | 0.05% | -55.8% | |
PARNF | PARNELL PHARMACEUT HLDGS LTD | $1,720,000 | -30.5% | 500,000 | 0.0% | 0.04% | -64.5% | |
ARRY | ARRAY BIOPHARMA INCcall | $1,368,000 | -36.8% | 300,000 | 0.0% | 0.03% | -66.7% | |
CERE | CERES INC | $1,106,000 | -44.6% | 1,024,020 | 0.0% | 0.02% | -70.9% | |
XOMA | XOMA CORP DELcall | $301,000 | -80.6% | 400,000 | 0.0% | 0.01% | -89.6% | |
CLCD | COLUCID PHARMACEUTICALS INC | $22,000 | -56.0% | 5,575 | 0.0% | 0.00% | -100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AGENUS INC | 42 | Q3 2023 | 1.9% |
IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
BEIGENE LTD | 28 | Q3 2023 | 7.4% |
BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-25 |
4 | 2024-03-13 |
4 | 2024-02-29 |
13F-HR | 2024-02-09 |
13F-HR | 2023-11-13 |
4 | 2023-10-16 |
13F-HR | 2023-08-11 |
4 | 2023-06-22 |
3 | 2023-06-15 |
4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.